Examiner: FIEBIG, RUSSELL G

Tech Center 1700 • Art Units: 1628 1651 1655 1792

This examiner grants 63% of resolved cases

Performance Statistics

62.7%

Allow Rate

-2.3% vs TC avg

936

Total Applications

+25.3%

Interview Lift

1108

Avg Prosecution Days

Based on 887 resolved cases, 2023–2026

11.7%

§101 Eligibility

8.1%

§102 Novelty

41.3%

§103 Obviousness

30.2%

§112 Clarity

App #	Title	Status	Assignee
18763336	SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM	Non-Final OA	The Chinese University of Hong Kong
18681862	COMPOSITION FOR PREVENTING OR AMELIORATING LOCOMOTIVE SYNDROME	Final Rejection	DIC Corporation

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.